이 에디터는 제약 분야 그중 약물 발견과 품질 관리 분야에서 12년 이상의 경력을 가진 풀타임 프리랜서 입니다. 2004년 이래로, 의학, 기술, 과학, 일반 분야에서 번역을 담당해 왔습니다.
Life sciences, Healthcare, Medical, Biochemistry, Chemistry, Pharmaceuticals, Energy Sector,\n Environmental Sciences, International Development, Poverty Alleviation, Sustainable Development, Human Rights, Farming, Water Management, Social Sciences, Gender Mainstreaming, Intercultural Communication, Education.\n
MSc, Organic Chemistry, University of Barcelona, Barcelona, UK BSc, Chemistry, University of Barcelona, Barcelona, UK
Identification of appropriate in vivo models to demonstrate the phenotypic consequence of modulating the autotaxin/lysophosphatidic acid receptor (ATX/LPAR) pathway, Cancer Research Technology, Discovery Laboratories, Wolfson Institute for Biomedical Research, University College London, Gower Street, London WC1E 6BT. Identification and characterisation of small molecule inhibitors of PAK4 as anti-cancer agents, RSC/SCI Protein Kinase 2012, Cambridge, UK, 21st-22nd May 2012 and Cambridge Cancer Centre Symposium, Cambridge, UK, 22nd June 2012. Identification and characterisation of small molecule inhibitors of phosphatidylinositol-4-phosphate 5-kinase (PIP5K), Cancer Research, May 1, 2009 69; 1782, National Cancer Research Institute Conference, Birmingham, UK, October 4-7, 2009. The discovery and optimization of pyrido[2,3-d]pyrimidine-2,4-diamines as potent and selective inhibitors of mTOR kinase, Bioorganic & Medicinal Chemistry Letters 19 (2009) 5950–5953. An efficient synthesis of N-substituted[1,4]benzodioxino-[2,3-f]isoindole-1,3-diones, University of Barcelona, 11th FECHEM Conference on Heterocycles in Bio-organic Chemistry.\n
Freelance Translator Cancer Research Technology, subsidiary of CRUK KuDOS Pharmaceuticals, subsidiary of AstraZeneca GlaxoSmithKline Genzyme Almirall Prodesfarma Laboratorios Viñas Servicios Científico Técnicos de la Universidad de Barcelona Centro Superior de Investigaciones Científicas \n